DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $80.14 million. The enterprise value is $79.87 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 6.77 million shares outstanding. The number of shares has increased by 63.70% in one year.
| Current Share Class | 6.77M |
| Shares Outstanding | 6.77M |
| Shares Change (YoY) | +63.70% |
| Shares Change (QoQ) | +26.46% |
| Owned by Insiders (%) | 14.86% |
| Owned by Institutions (%) | 5.01% |
| Float | 5.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.43 |
| Forward PS | 3.09 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 72.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.42.
| Current Ratio | 4.55 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.30 |
Financial Efficiency
Return on equity (ROE) is -63.42% and return on invested capital (ROIC) is -24.95%.
| Return on Equity (ROE) | -63.42% |
| Return on Assets (ROA) | -21.43% |
| Return on Invested Capital (ROIC) | -24.95% |
| Return on Capital Employed (ROCE) | -35.99% |
| Revenue Per Employee | $122,436 |
| Profits Per Employee | -$168,289 |
| Employee Count | 202 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, DarioHealth has paid $177,000 in taxes.
| Income Tax | 177,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.02% in the last 52 weeks. The beta is 1.08, so DarioHealth's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -23.02% |
| 50-Day Moving Average | 13.90 |
| 200-Day Moving Average | 12.89 |
| Relative Strength Index (RSI) | 44.11 |
| Average Volume (20 Days) | 29,912 |
Short Selling Information
The latest short interest is 178,541, so 2.64% of the outstanding shares have been sold short.
| Short Interest | 178,541 |
| Short Previous Month | 196,732 |
| Short % of Shares Out | 2.64% |
| Short % of Float | 3.44% |
| Short Ratio (days to cover) | 6.25 |
Income Statement
In the last 12 months, DarioHealth had revenue of $24.73 million and -$33.99 million in losses. Loss per share was -$11.36.
| Revenue | 24.73M |
| Gross Profit | 16.84M |
| Operating Income | -39.03M |
| Pretax Income | -42.14M |
| Net Income | -33.99M |
| EBITDA | -34.29M |
| EBIT | -39.03M |
| Loss Per Share | -$11.36 |
Full Income StatementBalance Sheet
The company has $31.91 million in cash and $31.64 million in debt, giving a net cash position of $269,000 or $0.04 per share.
| Cash & Cash Equivalents | 31.91M |
| Total Debt | 31.64M |
| Net Cash | 269,000 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 74.93M |
| Book Value Per Share | 11.07 |
| Working Capital | 32.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$26.79 million and capital expenditures -$137,000, giving a free cash flow of -$26.92 million.
| Operating Cash Flow | -26.79M |
| Capital Expenditures | -137,000 |
| Free Cash Flow | -26.92M |
| FCF Per Share | -$3.98 |
Full Cash Flow StatementMargins
Gross margin is 68.09%, with operating and profit margins of -157.82% and -171.09%.
| Gross Margin | 68.09% |
| Operating Margin | -157.82% |
| Pretax Margin | -170.38% |
| Profit Margin | -171.09% |
| EBITDA Margin | -138.66% |
| EBIT Margin | -157.82% |
| FCF Margin | n/a |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.70% |
| Shareholder Yield | -63.70% |
| Earnings Yield | -42.42% |
| FCF Yield | -33.60% |
Analyst Forecast
The average price target for DarioHealth is $50.00, which is 322.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $50.00 |
| Price Target Difference | 322.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -5.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.4 |
| Piotroski F-Score | 4 |